Title : 131I-Anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital.

Pub. Date : 2003 Aug

PMID : 14503945






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 131I-Anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital. Iodine-131 keratin 20 Homo sapiens